The Significance of the Data Exclusivity and Its Impact on Generic Drugs

9 Pages Posted: 12 Oct 2017 Last revised: 19 Oct 2017

See all articles by Srividhya Ragavan

Srividhya Ragavan

Texas A&M University School of Law

Date Written: July 1, 2017

Abstract

The law review in interview format outlines the issues in interpretation of data exclusivity under the TRIPS Agreement and the impact of data exclusivity on generic drugs.

Keywords: data exclusivity, intellectual property, TRIPS Agreement, generic drugs

JEL Classification: 024, 034, 038

Suggested Citation

Ragavan, Srividhya, The Significance of the Data Exclusivity and Its Impact on Generic Drugs (July 1, 2017). 1:1 JIPS 131 (2017), Texas A&M University School of Law Legal Studies Research Paper No. 17-80, Available at SSRN: https://ssrn.com/abstract=3051101

Srividhya Ragavan (Contact Author)

Texas A&M University School of Law ( email )

1515 Commerce Street
Fort Worth, TX 76102
United States

Do you want regular updates from SSRN on Twitter?

Paper statistics

Downloads
62
Abstract Views
1,039
rank
466,120
PlumX Metrics